Kymera Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2019
Total Assets: $116.7M
Liabilities Breakdown FY2019
Total Liabilities: $82.0M
Asset Breakdown
Total Assets: $116.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $76.0M | 65.1% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $3.8M | 3.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $36.9M | 31.6% |
Liabilities Breakdown
Total Liabilities: $82.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.3M | 4.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $78.8M | 96.0% |